Study Of Inflammatory Markers And Liver Enzymes In Alcoholic And Metabolic Dysfunction-associated Steatotic Liver Disease
Abstract
NAFLD and AFLD are leading causes of liver dysfunction globally.
NAFLD: Linked to obesity, insulin resistance, dyslipidemia.
AFLD: Caused by excessive alcohol intake.
Both can progress to steatohepatitis, fibrosis, and cirrhosis if untreated.
Inflammation is central markers like CRP, ESR, WBC reflect disease activity.
Liver enzymes (ALT, AST, ALP) indicate hepatocellular and cholestatic injury; their patterns differ in NAFLD and AFLD.
Objective: To compare inflammatory markers and enzyme profiles in NAFLD vs. AFLD, aiming to improve diagnosis and management.
References
Chalasani, N., Younossi, Z., Lavine, J. E., Charlton, M., Cusi, K., Rinella, M., & Sanyal, A. J. (2018). The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases. Hepatology, 67(1), 328–357.
Kowdley, K. V., Chalasani, N., Kistler, C. A., Abdelmalek, M. F., Diehl, A. M., & Sanyal, A. J. (2012). Alcoholic liver disease: Pathophysiology and management. Clinics in Liver Disease, 16(3), 593–607.
Lieber, C. S. (2004). Alcoholic fatty liver: Its pathogenesis and mechanism of progression to inflammation and fibrosis. Alcohol, 34(1), 9–19.
Ridker, P. M. (2003). C-reactive protein: A simple test to help predict risk of heart attack and stroke. Circulation, 108(12), e81–e85.
Volzke, H., Wallaschofski, H., Dörr, M., Hank, H., Robinson, D. M., John, U., & Kocher, T. (2005). High-sensitivity C-reactive protein as a predictor of nonalcoholic fatty liver disease in the general population. Hepatology, 42(5), 1100–1107.
Targher, G., Bertolini, L., Poli, F., Rodella, S., Scala, L., Tessari, R., ... & Falezza, G. (2007). Relations between carotid artery wall thickness and liver histology in subjects with nonalcoholic fatty liver disease. Diabetes Care, 30(8), 2119–2124.
Bugianesi, E., McCullough, A. J., & Marchesini, G. (2005). Insulin resistance: A metabolic pathway to chronic liver disease. Hepatology, 42(5), 987–1000.
Adams, L. A., Lymp, J. F., St Sauver, J. L., Sanderson, S. O., Lindor, K. D., Feldstein, A., & Angulo, P. (2005). The natural history of nonalcoholic fatty liver disease: A population-based cohort study. Gastroenterology, 129(1), 113–121.
Downloads
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
